ZenTech s.a.

ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for the screening of rare, genetic, chronic or infectious metabolic diseases in human body fluid samples. ZenTech specializes in supporting patients at early stages of life, focusing resources on developing a broad range of products for neonatal screening. The systematic screening performed in all asymptomatic newborns can detect the presence of serious and potentially treatable metabolic errors. This is the first essential step before a suitable treatment can be implemented to ensure optimal development and quality of life for newborns.